Evaluating the effectiveness of Rezum water vapor therapy for prostate enlargement

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to assess the safety and efficacy of Rezum water vapor thermal therapy in patients with benign prostatic hyperplasia (BPH). The study will enroll male participants aged 50 or older, who will undergo the Rezum procedure, which delivers steam directly into the prostate tissue to reduce its size. Participants will be monitored for at least three months post-treatment to evaluate outcomes related to efficacy and safety. The study is conducted in a day-surgery setting, minimizing recovery time for patients.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age 50 or older
* Prostate size between 30cc and 80cc as measured by transrectal ultrasound
* Patients scheduled for Rezum surgery for BPH

Exclusion Criteria:

* Suspected prostate cancer
* Suspected urinary tract infection
* Inability to complete follow-up
* Patients who do not consent to participate in the study

Where it's running

• Saint Vincent's Hospital
  Suwon, Gyeonggi-do, South Korea Recruiting

Study contacts

• Principal investigator: Hee Youn Kim, M.D., Ph.D. — St Vincent's Hospital
• Study coordinator: Hee Youn Kim, M.D., Ph.D.
• Email: khyoun10589@gmail.com
• Phone: 82-10-9024-6533

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Sonablate HIFU Registry for Prostate Cancer and BPH

  This registry collects real-world data from men treated with Sonablate HIFU to see how well it works and how it affects urinary and sexual function over the long term.

  Recruiting Sonablate · Indianapolis, Indiana · NCT07757490

• Tamsulosin alone vs. tamsulosin with tadalafil for troublesome urinary symptoms from enlarged prostate

  This study tests whether adding tadalafil to tamsulosin helps men with BPH see better urinary symptoms and quality of life, using two tadalafil doses over 12 weeks.

  Recruiting Ain Shams University · Cairo, Cairo Governorate · NCT07722884

• MRI-DTI look at the urethral sphincter ring and prostate base shape

  This imaging study tests how the male urethral internal sphincter ring appears on MRI-DTI and how it relates to prostate base morphology in men undergoing clinically indicated MRI.

  Recruiting Jiangsu Taizhou People's Hospital · Taizhou, Jiangsu · NCT07694752

• Tamsulosin With or Without Tadalafil for a Trial Without Catheter After Acute Urinary Retention

  This study tests whether adding tadalafil to tamsulosin helps men with a first episode of acute urinary retention due to enlarged prostate pass urine without needing a catheter.

  Recruiting Phase 4 Beni-Suef University · Banī Suwayf, Beni Suweif Governorate · NCT07654413

• Tamsulosin dose change or switch to silodosin before catheter removal in men with BPH-related acute urinary retention

  This trial tests whether continuing tamsulosin, increasing its dose, or switching to silodosin helps men with BPH-related acute urinary retention go without a catheter after seven days.

  Recruiting Phase 4 Beni-Suef University · Banī Suwayf, Beni Suweif Governorate · NCT07650968

• Water Vapor Therapy vs Ejaculation-Sparing Enucleation for Benign Prostatic Hyperplasia

  This study tests whether Water Vapor Thermal Therapy (Rezum) or an ejaculation-sparing enucleation procedure better helps sexually active men with bothersome BPH symptoms.

  Recruiting Beni-Suef University · Banī Suwayf, Beni Suweif Governorate · NCT07648888

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.